Positive preliminary results from Genomic Health’s Oncotype DX study in DCIS breast cancer
Positive preliminary results from Genomic Health’s Oncotype DX study in DCIS breast cancer
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Tags: breast, cancer, DCIS, From, Genomic, Health's, Oncotype, positive, Preliminary, Results, Study
Genomic Health Announces Positive Results From Large Prostate Cancer Gene Identification Study; Company to Proceed …
Genomic Health Announces Positive Results From Large Prostate Cancer Gene Identification Study; Company to Proceed …
Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy.  Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health’s Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic …
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: Announces, cancer, company., From, Gene, Genomic, health, identification, Large, positive, Proceed, prostate, Results, Study
Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association
Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association
Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).
Read more on News-Medical-Net
Categories: Breast Cancer Pain Tags: American, Association, Diffusion, heart, Pharmaceuticals, positive, presents, Results, Study
Plexxikon’s PLX4032 shows positive data in patients with metastatic melanoma
Plexxikon’s PLX4032 shows positive data in patients with metastatic melanoma
Plexxikon today announced positive preliminary data from a pivotal Phase 2 clinical trial of PLX4032 (RG7204) in metastatic melanoma, showing significant tumor shrinkage in the majority of patients.
Read more on News-Medical-Net
Categories: Breast Cancer Tumor Tags: Data, Melanoma, Metastatic, Patients, Plexxikon's, PLX4032, positive, Shows
Positive approach is effective tool in breast cancer battle
Positive approach is effective tool in breast cancer battle
“Cancer” is a word no one wants to hear, not from a doctor, a mother, a sister or a friend. It is a word that rips the world out from under us. In the moment it takes to utter those two small syllables, everything changes.
Read more on The Newburyport Current